The poor quality of streptokinase products in use in developing countries.
Longstaff
C
C
Thelwell
C
C
Whitton
C
C
D003257:Consumer Product Safety; D003906:Developing Countries; D004345:Drug Industry / Q000592:standards; D004591:Electrophoresis, Polyacrylamide Gel; D005337:Fibrin / Q000737:chemistry; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000592:standards*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000592:standards*; D010958:Plasminogen / Q000737:chemistry; D010960:Plasminogen Activators / Q000494:pharmacology* / Q000592:standards*; D011785:Quality Assurance, Health Care; D011786:Quality Control; D013300:Streptokinase / Q000737:chemistry* / Q000494:pharmacology*
D005343:Fibrinolytic Agents; D004364:Pharmaceutical Preparations; D005337:Fibrin; D010958:Plasminogen; D013300:Streptokinase; D010960:Plasminogen Activators